| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and lowers the price target from $285 to $280.
Morgan Stanley analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $31...
Deutsche Bank analyst Brian Bedell upgrades CME Group (NASDAQ:CME) from Hold to Buy and raises the price target from $266 to...
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade t...
CME Gr (NASDAQ:CME) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.63 by 1.79 p...